(Press-News.org) Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in patients whose positive axillary nodes at presentation convert to negative following neoadjuvant chemotherapy. These results were recently published in the New England Journal of Medicine.
The study enrolled 1,641 patients stratified by type of surgery (mastectomy, lumpectomy), hormone receptor status (ER-positive and/or PgR-positive; ER- and PgR-negative), HER2 status, adjuvant chemotherapy use, and pathologic complete response (pCR) in the breast, then randomized to RNI vs. No RNI. Anti-HER2 therapy was required for patients with HER2+tumors, as was endocrine therapy, for patients with hormone-sensitive tumors. The primary endpoint was invasive breast cancer recurrence-free interval (IBCRFI). Final analysis was planned after 172 events or 10 years post-study initiation. At the time-driven analysis, 109 IBCRFI events (63% of the planned 172) were confirmed. RNI did not significantly improve IBCRFI (HR=0.88, 95%CI 0.60-1.28; p=0.51, five-year point estimates: No RNI:91.8%, RNI:92.7%) and did not improve secondary endpoints of loco-regional recurrence-free interval, distant recurrence-free interval, disease-free survival, or overall survival.
“Although numerous prior clinical trials have demonstrated benefit from RNI in patients with positive axillary lymph nodes who undergo surgery first, this trial evaluated RNI in patients who presented with node-positive breast cancer but whose axillary lymph nodes converted to pathologically negative after neoadjuvant chemotherapy. Our study results demonstrate that pCR in axillary lymph nodes predicts for no benefit from RNI. We will continue follow-up for evaluation of longer-term outcomes for these patients,” stated Eleftherios Mamounas, MD, of AdventHealth Cancer Institute, and the lead author of the NRG-NSABP B-51/RTOG 1304 manuscript.
This study was funded by U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology SDMC), UG1CA189867 (NCORP), and U24CA180803 (IROC) from the National Cancer Institute (NCI), part of the National Institutes of Health; P30CA015083 (R.W. Mutter); Cancer Center Support Grant P30 CA008748 (A.J. Khan); and a Senior Scholar grant from the Susan G. Komen Foundation (R. Jagsi).
Citation
Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Lucas PC, Gupta N, Li XA, McCormick B, Smith BD, Tendulkar RD, Kavadi VS, Matsumoto K, Seaward SA, Irvin WJ Jr., Lin JY, Mutter RW, Muanza TM, Stromberg J, Jagsi R, Weiss A, Curran WJ Jr., Wolmark N. Omitting Regional Nodal Irradiation in Responders to Neoadjuvant Chemotherapy; (Accepted to New England Journal of Medicine). . Omitting Regional Nodal Irradiation in Responders to Neoadjuvant Chemotherapy; Published June 4, 2025; N Engl J Med 2025;392:2113-2124; DOI:10.1056/NEJMoa2414859 VOL. 392 NO. 21
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to carry out clinical trials with emphases on sex-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network.
END
NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative foll
Results from NRG-NSABP B-51 / RTOG 1304
2025-06-05
ELSE PRESS RELEASES FROM THIS DATE:
Cancer treatments should be licensed for all ages, oncologists say
2025-06-05
Recent advances have resulted in highly effective “tissue-agnostic” drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children. In an opinion paper publishing June 5 in the Cell Press journal Trends in Cancer, oncologists call for “ag(e)nostic” cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages.
“Cancer treatment in children is a huge unmet need. These drugs are extremely effective, and we want to see children have access to them,” says senior author Razelle ...
US self-reported race and ethnicity are poor proxies of genetic ancestry
2025-06-05
Genetic ancestry is much more complicated than how people report their race and ethnicity. New research, using data from the National Institutes of Health’s (NIH) All of Us Research Program, finds that people who identify as being from the same race or ethnic group can have a wide range of genetic differences. The findings are reported June 5 in the Cell Press journal the American Journal of Human Genetics.
As doctors and researchers learn more about how genetic variants influence the incidence and course of human diseases, the study of genetic ancestry has become increasingly important. This research is driving the field of precision medicine, ...
Living towers of worms observed in nature
2025-06-05
Nematodes are the most abundant animal on earth, but when times get tough, these tiny worms have a hard time moving up and out. So, they play to the strength of their clade. If food runs out and competition turns fierce, they slither towards their numerous kin. They climb onto each other and over one another until their bodies forge a living tower that twists skyward where they might hitch a ride on a passing animal to greener and roomier pastures.
At least that’s what scientists assumed. For decades, these worm structures ...
New AI transforms radiology with speed, accuracy never seen before
2025-06-05
CHICAGO --- A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology — boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist shortage, a large new study finds.
The findings will be published on Thursday (June 5) in JAMA Network Open.
“This is, to my knowledge, the first use of AI that demonstrably improves productivity, especially in health care. Even in other fields, I haven’t seen anything close to a 40% boost,” said senior author Dr. Mozziyar Etemadi, an assistant professor of anesthesiology ...
Brain mechanisms that distinguish imagination from reality discovered
2025-06-05
Areas of the brain that help a person differentiate between what is real and what is imaginary have been uncovered in a new study led by UCL researchers.
The research, published in Neuron, found that a region in the brain known as the fusiform gyrus – located behind one’s temples, on the underside of the brain’s temporal lobe – is involved in helping the brain to determine whether what we see is from the external world or generated by our imagination.
The researchers hope that their findings will increase understanding ...
Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration
2025-06-05
About The Study: In this cohort study, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with diabetes was associated with a 2-fold higher risk of incident neovascular age-related macular degeneration development than among similar patients with diabetes who did not receive a GLP-1 RA. Further research is needed to elucidate the exact pathophysiological mechanisms involved and to understand the trade-offs between the benefits and risks of GLP-1 RAs.
Corresponding Author: To ...
BMI, physical activity, and subsequent neoplasm risk among childhood cancer survivors
2025-06-05
About The Study: Among childhood cancer survivors in this cohort study, obesity was associated with an increased risk for multiple subsequent neoplasm types, while higher physical activity was associated with reduced subsequent neoplasm risk. Lifestyle interventions should be considered in future subsequent neoplasm prevention research.
Corresponding Author: To contact the corresponding author, Lenat Joffe, MD, MS, email ljoffe@northwell.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2025.1340)
Editor’s Note: Please see the article for additional ...
Chimpanzees can catch yawns from androids
2025-06-05
Chimpanzees (Pan troglodytes) can ‘catch’ yawns from an android imitating human facial expressions, according to new research from City St George’s, University of London.
The study, published in Scientific Reports, demonstrates that chimpanzees will both yawn and lie down in response to yawns made by an android, suggesting that it may act as a cue to rest rather than simply triggering an automatic response.
The findings appear to show contagious yawning due to an inanimate model for the first time, according to the authors, and the study also ...
The Holberg Prize conferred upon Professor Gayatri Chakravorty Spivak
2025-06-05
At a prestigious award ceremony today in the University Aula in Bergen, Gayatri Chakravorty Spivak received the international research award from HRH Crown Prince Haakon of Norway. Spivak is University Professor in the Humanities at Columbia University.
The Holberg Prize is worth NOK 6 million (approx. USD 600,000) and is awarded annually for outstanding contributions to research in the humanities, social sciences, law or theology.
Expressing her deepest gratitude as well as her surprise on receiving the award, Spivak accepted the Holberg ...
Up and running—first room-temperature quantum accelerator of its kind in Europe
2025-06-05
To further accelerate its pioneering research in the field of quantum computing, the Fraunhofer Institute for Applied Solid State Physics IAF is expanding its unique quantum computing infrastructure with the latest system from Quantum Brilliance (QB).
Following a public tender, the Quantum Development Kit (QB-QDK2.0) is operational and integrated directly into the high-performance computing infrastructure at Fraunhofer IAF. The system requires no cryogenics, fits into a standard 19” server rack, and enables energy-efficient, hybrid quantum-classical computing in conventional IT environments. ...
LAST 30 PRESS RELEASES:
Scientists target ‘molecular machine’ in the war against antimicrobial resistance
Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting
Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating
Thunderstorms are a major driver of tree death in tropical forests
Danforth Plant Science Center adds two new faculty members
Robotic eyes mimic human vision for superfast response to extreme lighting
Racial inequities and access to COVID-19 treatment
Residential segregation and lung cancer risk in African American adults
Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’
Capturability distinction analysis of continuous and pulsed guidance laws
CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day
Exposure to air pollution may cause heart damage
SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight
Prebiotics might be a factor in preventing or treating issues caused by low brain GABA
Youngest in class at higher risk of mental health problems
American Heart Association announces new volunteer leaders for 2025-26
Gut microbiota analysis can help catch gestational diabetes
FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship
Champions for change – Paid time off initiative just made clinical trials participation easier
Fentanyl detection through packaging
Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics
New 3D glacier visualizations provide insights into a hotter Earth
Creativity across disciplines
Consequences of low Antarctic sea ice
Hear here: How loudness and acoustic cues help us judge where a speaker is facing
A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America
Epilepsy self-management program shows promise to control seizures, improve mood and quality of life
Fat may play an important role in brain metabolism
New study finds no lasting impact of pandemic pet ownership on human well-being
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
[Press-News.org] NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative follResults from NRG-NSABP B-51 / RTOG 1304